Service de Néphrologie et Transplantation, Hôpital Henri Mondor, Centre de référence maladie rare Syndrome Néphrotique Idiopathique, Institut Francilien de recherche en Néphrologie et Transplantation (IFRNT), INSERM U955, Université Paris Est Créteil, APHP (Assistance Publique-Hôpitaux de Paris, Créteil), Créteil, France.
Service de Néphrologie et Transplantation, Hôpital Henri Mondor, Centre de référence maladie rare Syndrome Néphrotique Idiopathique, Institut Francilien de recherche en Néphrologie et Transplantation (IFRNT), INSERM U955, Université Paris Est Créteil, APHP (Assistance Publique-Hôpitaux de Paris, Créteil), Créteil, France.
Am J Kidney Dis. 2014 May;63(5):816-9. doi: 10.1053/j.ajkd.2013.12.014. Epub 2014 Feb 8.
We report an occurrence of progressive loss of transplant function and ultimately transplant failure after living related kidney transplantation involving monozygotic twin brothers of Afro-Caribbean origin who were both heterozygous for the G1 and G2 kidney disease risk alleles in the APOL1 gene, which encodes apolipoprotein L-I. A 21-year-old man with end-stage kidney disease of unknown cause received a kidney from his brother, who was confirmed as a monozygotic twin by microsatellite analysis. Thirty months after transplantation, the patient presented with proteinuria and decreased estimated glomerular filtration rate; a biopsy of the transplant showed typical focal segmental glomerulosclerosis lesions. He received steroid therapy, but progressed to kidney failure 5 years later. The twin brother had normal kidney function without proteinuria at the time of transplantation; however, 7 years later, he was found to have decreased estimated glomerular filtration rate (40mL/min/1.73m(2)) and proteinuria (protein excretion of 2.5g/d). APOL1 genotyping revealed that both donor and recipient were heterozygous for the G1 and G2 alleles. This case is in stark contrast to the expected course of kidney transplantation in identical twins and suggests a role for APOL1 polymorphisms in both the donor and recipient.
我们报告了一例亲缘活体肾移植后移植物功能进行性丧失和最终衰竭的病例。供受者均为非洲裔加勒比血统的同卵双胞胎,他们在编码载脂蛋白 L-I 的 APOL1 基因中均为 G1 和 G2 肾病风险等位基因的杂合子。一名 21 岁的男性因不明原因的终末期肾病接受了其兄弟的肾脏,该兄弟通过微卫星分析被确认为同卵双胞胎。移植后 30 个月,患者出现蛋白尿和估计肾小球滤过率下降;移植肾活检显示典型的局灶节段性肾小球硬化病变。他接受了类固醇治疗,但 5 年后进展为肾衰竭。供体在移植时肾功能正常,无蛋白尿;然而,7 年后,他被发现估计肾小球滤过率(40mL/min/1.73m(2))下降和蛋白尿(蛋白尿排泄 2.5g/d)。APOL1 基因分型显示供者和受者均为 G1 和 G2 等位基因的杂合子。这种情况与同卵双胞胎的预期肾脏移植过程形成鲜明对比,提示 APOL1 多态性在供者和受者中均起作用。